ACUVUE THERAVISION WITH KETOTIFEN Drug Patent Profile
✉ Email this page to a colleague
When do Acuvue Theravision With Ketotifen patents expire, and when can generic versions of Acuvue Theravision With Ketotifen launch?
Acuvue Theravision With Ketotifen is a drug marketed by Johnson Johnson Visn and is included in one NDA. There are two patents protecting this drug.
This drug has forty-four patent family members in fifteen countries.
The generic ingredient in ACUVUE THERAVISION WITH KETOTIFEN is ketotifen fumarate. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ketotifen fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acuvue Theravision With Ketotifen
A generic version of ACUVUE THERAVISION WITH KETOTIFEN was approved as ketotifen fumarate by APOTEX INC on May 9th, 2006.
Summary for ACUVUE THERAVISION WITH KETOTIFEN
International Patents: | 44 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ACUVUE THERAVISION WITH KETOTIFEN? | ACUVUE THERAVISION WITH KETOTIFEN excipients list |
DailyMed Link: | ACUVUE THERAVISION WITH KETOTIFEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ACUVUE THERAVISION WITH KETOTIFEN
US Patents and Regulatory Information for ACUVUE THERAVISION WITH KETOTIFEN
ACUVUE THERAVISION WITH KETOTIFEN is protected by two US patents and one FDA Regulatory Exclusivity.
Patents protecting ACUVUE THERAVISION WITH KETOTIFEN
Methods for stabilizing oxidatively unstable compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods and ophthalmic devices used in the treatment of ocular allergies
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
FDA Regulatory Exclusivity protecting ACUVUE THERAVISION WITH KETOTIFEN
NEW PRODUCT
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Johnson Johnson Visn | ACUVUE THERAVISION WITH KETOTIFEN | ketotifen fumarate | DRUG-ELUTING CONTACT LENS;OPHTHALMIC | 022388-001 | Feb 25, 2022 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ACUVUE THERAVISION WITH KETOTIFEN
See the table below for patents covering ACUVUE THERAVISION WITH KETOTIFEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | PI0718374 | mÉtodos e dispositivos oftÁlmicos usados no tratamento de alergias oculares | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2007109523 | ⤷ Try a Trial | |
South Korea | 20090092763 | METHODS AND OPHTHALMIC DEVICES USED IN THE TREATMENT OF OCULAR ALLERGIES | ⤷ Try a Trial |
Argentina | 059928 | METODOS Y DISPOSITIVOS OFTALMICOS USADOS EN EL TRATAMIENTO DE ALERGIAS OCULARES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |